Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.
2.

Abnormal expression of adhesion protein Bves is associated with gastric cancer progression and poor survival.

Luo D, Huang H, Lu ML, Zhao GF, Chang J, Zheng MY, Wang Y.

Pathol Oncol Res. 2012 Apr;18(2):491-7. doi: 10.1007/s12253-011-9472-x. Epub 2011 Nov 23.

PMID:
22109561
3.

Beclin 1 expression is an independent prognostic factor for gastric carcinomas.

Yu M, Gou WF, Zhao S, Xiao LJ, Mao XY, Xing YN, Takahashi H, Takano Y, Zheng HC.

Tumour Biol. 2013 Apr;34(2):1071-83. doi: 10.1007/s13277-013-0648-8. Epub 2013 Jan 19.

PMID:
23334926
4.

Overexpression of KPNA2 correlates with poor prognosis in patients with gastric adenocarcinoma.

Li C, Ji L, Ding ZY, Zhang QD, Huang GR.

Tumour Biol. 2013 Apr;34(2):1021-6. doi: 10.1007/s13277-012-0641-7. Epub 2013 Jan 3.

PMID:
23283818
5.

Overexpression of YAP1 is correlated with progression, metastasis and poor prognosis in patients with gastric carcinoma.

Hu X, Xin Y, Xiao Y, Zhao J.

Pathol Oncol Res. 2014 Oct;20(4):805-11. doi: 10.1007/s12253-014-9757-y. Epub 2014 Mar 19.

PMID:
24643316
6.

High monocarboxylate transporter 4 protein expression in stromal cells predicts adverse survival in gastric cancer.

Yan P, Li YH, Tang ZJ, Shu X, Liu X.

Asian Pac J Cancer Prev. 2014;15(20):8923-9.

7.

Clinicopathologic features and prognosis analysis of mucinous gastric carcinoma.

Yin C, Li D, Sun Z, Zhang T, Xu Y, Wang Z, Xu H.

Med Oncol. 2012 Jun;29(2):864-70. doi: 10.1007/s12032-011-9825-z. Epub 2011 Feb 5.

PMID:
21298368
8.

The pathobiological behaviors and prognosis associated with Japanese gastric adenocarcinomas of pure WHO histological subtypes.

Zheng HC, Zheng YS, Xia P, Xu XY, Xing YN, Takahashi H, Guan YF, Takano Y.

Histol Histopathol. 2010 Apr;25(4):445-52. doi: 10.14670/HH-25.445.

PMID:
20183797
9.

β-arrestin1 over-expression is associated with an unfavorable prognosis in lung adenocarcinomas and correlated with vascular endothelial growth factor.

Qiu C, Zheng C, Zhu L, Qu X, Shen H, Du J.

Int J Clin Exp Pathol. 2015 Apr 1;8(4):3785-93. eCollection 2015.

10.

Prognostic significance of ADAM17 expression in patients with gastric cancer who underwent curative gastrectomy.

Aydin D, Bilici A, Yavuzer D, Kefeli U, Tan A, Ercelep O, Mert A, Yuksel S, Ozcelik M, Isik D, Surmeli H, Odabasi H, Aliustaoglu M.

Clin Transl Oncol. 2015 Aug;17(8):604-11. doi: 10.1007/s12094-015-1283-1. Epub 2015 Mar 19.

PMID:
25786367
11.
12.

Loss of ACSS2 expression predicts poor prognosis in patients with gastric cancer.

Hur H, Kim YB, Ham IH, Lee D.

J Surg Oncol. 2015 Nov;112(6):585-91. doi: 10.1002/jso.24043. Epub 2015 Sep 18.

PMID:
26381042
13.

CEACAM5 has different expression patterns in gastric non-neoplastic and neoplastic lesions and cytoplasmic staining is a marker for evaluation of tumor progression in gastric adenocarcinoma.

Liu JN, Wang HB, Zhou CC, Hu SY.

Pathol Res Pract. 2014 Oct;210(10):686-93. doi: 10.1016/j.prp.2014.06.024. Epub 2014 Jul 1.

PMID:
25042385
14.

Low expression of SOCS-1 and SOCS-3 is a poor prognostic indicator for gastric cancer patients.

Li G, Xu J, Wang Z, Yuan Y, Li Y, Cai S, He Y.

J Cancer Res Clin Oncol. 2015 Mar;141(3):443-52. doi: 10.1007/s00432-014-1838-5. Epub 2014 Sep 28.

PMID:
25261987
15.

Aberrant SERCA3 expression is closely linked to pathogenesis, invasion, metastasis, and prognosis of gastric carcinomas.

Xu XY, Gou WF, Yang X, Wang GL, Takahashi H, Yu M, Mao XY, Takano Y, Zheng HC.

Tumour Biol. 2012 Dec;33(6):1845-54. doi: 10.1007/s13277-012-0444-x. Epub 2012 Sep 5.

PMID:
22948776
16.

Paradoxical expression of maspin in gastric carcinomas: correlation with carcinogenesis and progression.

Yu M, Zheng H, Tsuneyama K, Takahashi H, Nomoto K, Xu H, Takano Y.

Hum Pathol. 2007 Aug;38(8):1248-55. Epub 2007 May 8.

PMID:
17490717
17.

High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer.

Wang YY, Ye ZY, Zhao ZS, Tao HQ, Chu YQ.

Ann Surg Oncol. 2010 Jan;17(1):89-97. doi: 10.1245/s10434-009-0722-z. Epub 2009 Oct 10.

PMID:
19820999
18.

Adiponectin receptor expression in gastric carcinoma: implications in tumor development and progression.

Shin E, Park DJ, Kim HH, Won NH, Choe G, Lee HS.

J Cancer Res Clin Oncol. 2013 Apr;139(4):709-18. doi: 10.1007/s00432-013-1379-3. Epub 2013 Jan 29.

PMID:
23358721
19.

Expression of {beta}-catenin, MUC1 and c-met in diffuse-type gastric carcinomas: correlations with tumour progression and prognosis.

Retterspitz MF, Mönig SP, Schreckenberg S, Schneider PM, Hölscher AH, Dienes HP, Baldus SE.

Anticancer Res. 2010 Nov;30(11):4635-41.

PMID:
21115917
20.

Expression levels of cyclin G2, but not cyclin E, correlate with gastric cancer progression.

Choi MG, Noh JH, An JY, Hong SK, Park SB, Baik YH, Kim KM, Sohn TS, Kim S.

J Surg Res. 2009 Dec;157(2):168-74. doi: 10.1016/j.jss.2008.06.020. Epub 2008 Jul 15.

PMID:
19559447

Supplemental Content

Support Center